This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to American Regent Inc., a pharmaceutical manufacturer and distributor, for the supply of glycopyrrolate 0.2 mg/ml injection solution. The delivery order, valued at $1,220.00, is a firm fixed-price contract with no set-aside designation. American Regent Inc. is a subsidiary of the Daiichi Sankyo Group and specializes in injectable drugs and sterile pharmaceutical preparations. The company has a robust...
This federal contract award, valued at $1,220.00, was granted to American Regent Inc., a pharmaceutical manufacturer and distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of glycopyrrolate 0.2 mg/ml injection solution, a critical care medication. This is a firm-fixed-price delivery order contract with no set-aside designation. American Regent Inc. is a subsidiary of the Daiichi Sankyo Group and specializes in injectable drugs and sterile...
American Regent Inc. was awarded a $5,462.56 firm fixed price delivery order for 0.2 mg/ml glycopyrrolate injection solution by the Defense Logistics Agency Troop Support Medical. The delivery order was awarded on April 8, 2022 under the agency's indefinite-delivery/indefinite-quantity prime vendor medical contract and has an anticipated completion date of April 13, 2022. The place of performance will be American Regent's facility located in East Yaphank, New York. No set-aside provision was...
The Defense Logistics Agency Troop Support Medical awarded a $2,731.28 firm fixed price delivery order to American Regent Inc. for 4557119035 - Glycopyrrolate 0.2 mg/ml injection solution. The place of performance is East Yaphank, New York. No set-aside designation was used for this contract. As the agency responsible for worldwide logistics support in the Department of Defense, this delivery order will provide Glycopyrrolate injection to the DLA Troop Support Medical in support of its mission...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,287.86, is for the delivery of the pharmaceutical product glycopyrrolate injection. It is a firm-fixed-price contract with an ultimate completion date of August 19, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,600.26, is for the delivery of the medication glycopyrrolate injection. It is a firm-fixed-price delivery order contract without a set-aside, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of glycopyrrolate injection and other medical products and prescription drugs. The contract is a Delivery Order valued at $1,456.33 with a firm fixed price, awarded on May 22, 2024 and set to be completed by May 23, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,476.75 delivery order contract is for the supply of GLYCOPYRROLATE 4 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has an ultimate completion date of October 26, 2023 and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4 mg/20 ml vials of glycopyrrolate, a medication used for various medical conditions. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $11,511.25 and a completion date of November 3, 2023. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,845.60 firm-fixed-price delivery order is for the supply of glycopyrrolate 1 mg/5 ml vials, a medication used to treat certain conditions. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...